What's the highest dose of Mounjaro — and how do you get there?

You've been on Mounjaro a few weeks and you're wondering: what does 15 mg actually do differently?

It's a question our prescribers hear most weeks, usually around the time someone's settling into their third or fourth pen. The short answer is that 15 mg is the highest licensed dose of tirzepatide in the UK, and the clinical trial data behind it is striking. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, adults taking 15 mg tirzepatide achieved an average body-weight reduction of around 20–21% over 72 weeks, figures that genuinely shifted how clinicians think about medical weight management. Some analyses put the figure slightly higher still, depending on the population studied.

What makes tirzepatide different from other GLP-1 medicines is its dual mechanism: it activates both GIP and GLP-1 receptors simultaneously. That combination slows gastric emptying, increases feelings of fullness, and influences how the body handles blood sugar, effects that compound as the dose rises. At 15 mg, both receptor pathways are working at their maximum licensed intensity. That said, reaching 15 mg isn't a race. A prescriber weighs up how much weight you're losing at your current dose, how well you're tolerating it, and whether stepping up is clinically justified.

You can read more about how the highest dose of tirzepatide compares in practice on a dedicated page, but the core point stands: 15 mg is the top of the licensed range, not a starting point.

Working up to 15 mg, what the titration schedule actually looks like

Mounjaro's dosing ladder has six rungs: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The 2.5 mg pen is a tolerability step, its job is to let your digestive system adapt to tirzepatide before therapeutic doses begin. Most people find that any nausea or gastrointestinal discomfort peaks in the first week or two after each step up, then settles. Moving too quickly disrupts that settling-in window and makes side effects harder to manage.

Under the standard schedule, each dose runs for roughly four weeks before a prescriber considers moving up. That's a minimum, not a deadline. If someone is still managing symptoms at 7.5 mg, a prescriber might hold there for eight weeks rather than push to 10 mg. Equally, if someone is tolerating 10 mg well but losing weight steadily, there's a clinical conversation to be had about whether 12.5 mg or 15 mg would add meaningful benefit. Not everyone needs the highest dosage of Mounjaro to reach their goals, and the 5 mg pen, for example, is where many people find a comfortable and effective maintenance point.

The NHS medicines page for tirzepatide gives a clear patient-level overview of the dosing schedule and what to expect at each stage. Always follow the specific guidance your prescriber gives you, and check the Patient Information Leaflet that comes with your pen, it covers storage, missed doses, and timing in detail that no article can fully substitute.

When 15 mg might be reached, and when it might not be the aim

Reaching what is the highest dose of Mounjaro depends on two things: tolerability and clinical need. NICE's appraisal of tirzepatide notes that if someone hasn't lost at least 5% of their body weight after six months at the highest tolerated dose, continuing should be reviewed. That framing is deliberate, it's the highest tolerated dose, not the highest possible dose. Some people plateau at 12.5 mg due to side effects; others find 15 mg the first dose where weight loss really accelerates.

Side effects at higher doses tend to mirror those at lower ones (nausea, constipation, diarrhoea, and indigestion are the most reported) but can be more pronounced after each step up. The adjustment window usually passes. Serious reactions are uncommon, but anyone experiencing severe, persistent stomach pain that seems to radiate to the back should seek medical attention promptly, as pancreatitis is a known though infrequent risk with GLP-1 medicines. If you're unsure which dose is right for your situation, or you've been told to reduce your Mounjaro dose, that's a conversation your prescriber should lead.

Thinking about starting or reviewing your treatment? You can explore more about Mounjaro, including how it's used for weight management in the UK, before speaking to a clinician. For a broader look at the options available, the weight-loss treatment overview sets out where tirzepatide sits alongside other licensed medicines. When you're ready to have your eligibility assessed by a GPhC-registered prescriber, checking your eligibility with our clinical team is a straightforward first step, there's no commitment involved, and the consultation is free.